A novel perspective on natural therapeutic approaches in glaucoma therapy

M Mozaffarieh, J Flammer - Expert Opinion on Emerging Drugs, 2007 - Taylor & Francis
M Mozaffarieh, J Flammer
Expert Opinion on Emerging Drugs, 2007Taylor & Francis
Glaucoma is becoming recognised as a condition for which not only elevated intraocular
pressure (IOP), but also non-pressure-dependent risk factors, are responsible. Better
knowledge of the pathogenesis has opened up new thera-peutic approaches that are often
referred to as non-IOP-lowering treatment. These new avenues of treatment, some of which
are still under investigation, include agents that can improve vascular regulation and blood
flow to the eye and reduce oxidative stress. Vascular regulation can be improved …
Glaucoma is becoming recognised as a condition for which not only elevated intraocular pressure (IOP), but also non-pressure-dependent risk factors, are responsible. Better knowledge of the pathogenesis has opened up new thera-peutic approaches that are often referred to as non-IOP-lowering treatment. These new avenues of treatment, some of which are still under investigation, include agents that can improve vascular regulation and blood flow to the eye and reduce oxidative stress. Vascular regulation can be improved systemically with magnesium. Dark chocolate and omega-3-fatty acids can also improve blood flow regulation. Oxidative stress at mitochondrial level can be reduced by gingko. Polyphenolic flavonoids (tea, coffee and red wine), anthocyanosides, ubiquinone and melatonin have antioxidant properties, and heat-shock proteins can be induced naturally by the use of sauna baths. Future intensive studies on the effect of these compounds may open up a new therapeutic era in glaucoma.
Taylor & Francis Online
以上显示的是最相近的搜索结果。 查看全部搜索结果